magolibero
..se la sà gira..
Ultima modifica:
NicOx.... in attesa di.....
- Creatore Discussione DickSIM
- Data di Inizio
viralic
Forumer storico
viralic
Forumer storico
DickSIM
Prima o poi....ci becco!
quella nn ci manca.....
sono quanti anni che siamo nicoxiani??
TANTI!
ps: nn me ne vogliano ma a me piace solo la ROBINSON
magolibero
..se la sà gira..
che sarebbe questo..
Nicox - News Detail
June 19, 2013.
Sophia Antipolis, France.
Nicox S.A.(NYSE Euronext Paris: COX) announced today that it has entered into an exclusive agreement with Immco Diagnostics Inc.(“Immco”), a worldwide leader in autoimmune diagnostic products and services...
la cosa buffa ( buffa ?!?..
) é il risultato che fornisce il traduttore automatico inglese%italiano del termine IMMCO => causare risultati non attendibiliproprio l'acronimo adatto per una azienda di test diagnostici..
se poi vogliamo rimanere nella pura accezione dei termini in italiano , la Immco é una delle tante società immobiliari della Galassia coinvolte nel crac del gruppo Ligresti.. di bene in meglio
PIZZODIGINO
Pacifico
PIZZODIGINO
Pacifico
Dunque la tecnologia dell'ossido nitrico non è ancora morta; abbiamo il latanoprostene bunod in fase III, il naproxcinod ancora in pista e la molecola di Merck che attende di conoscere il suo futuro. Chissà se almeno una su tre giungerà sul bancone di una farmacia ?
PIZZODIGINO
Pacifico
Ma ve lo immaginate Guly anziano, che ha l'artrosi al ginocchio, va in farmacia e gli danno il Naproxcinod; per la rabbia gli sale la pressione e deve tornare in farmacia dove gli danno la molecola che Nicox stà sviluppando con Merck; fuori di se, gli schizzano gli occhi dalle orbite, deve tornare in farmacia e gli danno il latanoprostene bunod.
Insomma da capo dei detrattori di Nicox, diventa il migliore cliente dei prodotti Nicox.
Naturalmente caro Guly, ti auguro un futuro senza malattie varie, ma mi viene da ridere a pensarti a pagare un prodotto targato Nicox.
Insomma da capo dei detrattori di Nicox, diventa il migliore cliente dei prodotti Nicox.
Naturalmente caro Guly, ti auguro un futuro senza malattie varie, ma mi viene da ridere a pensarti a pagare un prodotto targato Nicox.
PIZZODIGINO
Pacifico
La Société annonce également l’extension de son portefeuille de produits avec la signature d’un accord exclusif d’approvisionnement et de distribution portant sur une gamme de produits de santé oculaire conclu avec une société pharmaceutique
européenne non cotée spécialisée en ophtalmologie dont le nom n’est pas divulgué.Aeripharma è made in USA, quindi non può essere la società in oggetto; poi i suoi prodotti sono solo in fase clinica II, quindi ancora lontani dalla commercializzazione.
tradermen
Forumer storico
Election of Vicente Anido, Jr. to Nicox’s Board of Directors - Vaughn Kailian re-elected Director
Election of Vicente Anido and re-election of Vaughn Kailian to the Company's Board of Directors for a period of four years. Bengt Samuelsson and Jorgen Buus Lassen have retired from the Board, due to their reaching the age limit set out in the Company’s by-laws.
June 21, 2013.
Sophia Antipolis, France.
Nicox S.A. (NYSE Euronext Paris: COX) today announced the election of Vicente Anido, Jr., PhD., to the Company’s Board of Directors for a period of four years. Dr. Anido is a highly experienced and respected leader in the ophthalmology sector and most recently served as President and Chief Executive Officer of ISTA Pharmaceuticals prior to its acquisition by Bausch + Lomb.
The Company also announced that Vaughn Kailian, Managing Director at MPM Capital and former President & CEO of COR Therapeutics, has been re-elected as a member of the Board of Directors for a period of four years. Bengt Samuelsson and Jorgen Buus Lassen have retired from the Board due to their reaching the age limit set out in the Company’s by-laws.
“I am honoured to join Nicox’s Board of Directors. The Company already has a number of promising assets and a sound strategy to become an international and innovative ophthalmic company. I look forward to sharing my experience and contributing to the future growth of the business”, said Vicente Anido.
“We are pleased to welcome Vicente Anido as a member of the Nicox Board of Directors and would also like to thank Vaughn Kailian for his continued support for Nicox as a Board member” said Michele Garufi, Chief Executive Officer of Nicox. “We look forward to their unique contributions as we continue to transform Nicox into a leading international ophthalmology company.”
“On behalf of the Board, Nicox’s management and its employees I would like to express my sincere gratitude to Bengt Samuelsson and Jorgen Buus Lassen. Their guidance and support has been of great value to the Company over the past fifteen years, particularly during our current period of transition.”
Download File
Election of Vicente Anido and re-election of Vaughn Kailian to the Company's Board of Directors for a period of four years. Bengt Samuelsson and Jorgen Buus Lassen have retired from the Board, due to their reaching the age limit set out in the Company’s by-laws.
June 21, 2013.
Sophia Antipolis, France.
Nicox S.A. (NYSE Euronext Paris: COX) today announced the election of Vicente Anido, Jr., PhD., to the Company’s Board of Directors for a period of four years. Dr. Anido is a highly experienced and respected leader in the ophthalmology sector and most recently served as President and Chief Executive Officer of ISTA Pharmaceuticals prior to its acquisition by Bausch + Lomb.
The Company also announced that Vaughn Kailian, Managing Director at MPM Capital and former President & CEO of COR Therapeutics, has been re-elected as a member of the Board of Directors for a period of four years. Bengt Samuelsson and Jorgen Buus Lassen have retired from the Board due to their reaching the age limit set out in the Company’s by-laws.
“I am honoured to join Nicox’s Board of Directors. The Company already has a number of promising assets and a sound strategy to become an international and innovative ophthalmic company. I look forward to sharing my experience and contributing to the future growth of the business”, said Vicente Anido.
“We are pleased to welcome Vicente Anido as a member of the Nicox Board of Directors and would also like to thank Vaughn Kailian for his continued support for Nicox as a Board member” said Michele Garufi, Chief Executive Officer of Nicox. “We look forward to their unique contributions as we continue to transform Nicox into a leading international ophthalmology company.”
“On behalf of the Board, Nicox’s management and its employees I would like to express my sincere gratitude to Bengt Samuelsson and Jorgen Buus Lassen. Their guidance and support has been of great value to the Company over the past fifteen years, particularly during our current period of transition.”
Download File
